ORIGINAL INVESTIGATION. Risk Factors for Coronary Heart Disease in African Americans. The Atherosclerosis Risk in Communities Study,

Size: px
Start display at page:

Download "ORIGINAL INVESTIGATION. Risk Factors for Coronary Heart Disease in African Americans. The Atherosclerosis Risk in Communities Study,"

Transcription

1 ORIGINAL INVESTIGATION Risk Factors for Coronary Heart Disease in African Americans The Atherosclerosis Risk in Communities Study, Daniel W. Jones, MD; Lloyd E. Chambless, PhD; Aaron R. Folsom, MD; Gerardo Heiss, MD; Richard G. Hutchinson, MD; A. Richey Sharrett, MD, DrPh; Moyses Szklo, MD, DrPh; Herman A. Taylor, Jr, MD Background: As part of the Atherosclerosis Risk in Communities Study, the race-specific incidence rates and risk factor prediction for coronary heart disease (CHD) were determined for black and white persons over 7 to 10 years of follow-up, from 1987 to Methods: The sample included men and women (2298 black women, 5686 white women, 1396 black men, and 4682 white men) aged 45 to 64 years who were free of clinical CHD at baseline. Results: Average age-adjusted incidence rates (95% confidence intervals) for CHD per 1000 person-years were as follows: black women, 5.1 ( ); white women, 4.0 ( ); black men, 10.6 ( ); and white men, 12.5 ( ). Incidence rates (95% confidence intervals) using a definition for CHD that excluded revascularization procedures were as follows: black women, 4.9 ( ); white women, 2.9 ( ); black men, 9.2 ( ); and white men, 7.9 ( ). In a multivariable analysis, hypertension was a particularly strong risk factor in black women, with hazard rate ratios (95% confidence intervals) as follows: black women, 4.8 ( ); white women, 2.1 ( ); black men, 2.0 ( ); and white men, 1.6 ( ). Diabetes mellitus was somewhat more predictive in white women than in other groups. Hazard rate ratios (95% confidence intervals) were as follows: black women, 1.8 ( ); white women, 3.3 ( ); black men, 1.6 ( ); and white men, 2.0 ( ). Low-density lipoprotein cholesterol level was similarly predictive in all race-sex groups (hazard rate ratio, per SD increment of low-density lipoprotein cholesterol level). High-density lipoprotein cholesterol level seemed somewhat more protective in white than in black persons. Conclusions: Findings from this study, along with clinical trial evidence showing efficacy, support aggressive management of traditional risk factors in black persons, as in white persons. Understanding the intriguing racial differences in risk factor prediction may be an important part of further elucidating the causes of CHD and may lead to better methods of preventing and treating CHD. Arch Intern Med. 2002;162: From the Divisions of Hypertension (Dr Jones) and Cardiology (Drs Hutchinson and Taylor), the Department of Medicine, The University of Mississippi Medical Center, Jackson; the Departments of Biostatistics (Dr Chambless) and Epidemiology (Dr Heiss), School of Public Health, University of North Carolina at Chapel Hill; the Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis (Dr Folsom); National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Sharrett); and the Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Md (Dr Szklo). THE RELATIONSHIP between incidence of coronary heart disease (CHD) and standard risk factors, including low-density lipoprotein (LDL) cholesterol level, high-density lipoprotein (HDL) cholesterol level, blood pressure, smoking, and diabetes mellitus, is well established and is described in several populations, including participants of the Atherosclerosis Risk in Communities (ARIC) Study. 1-4 However, race-specific CHD incidence data for black persons are sparse and, to our knowledge, have not yet been reported for participants of the ARIC Study Race as a health factor is a complex subject. Controversy exists as to whether health issues should even be considered in terms of race, because race is defined with such difficulty and intertwined with socioeconomic status Nevertheless, the disparity in health outcomes based on assessment by race is well documented This analysis attempts to quantify the risk factor associations for CHD in black persons, with a comparison group of white persons in the same standardized study. One of the unique features of the ARIC Study, a large population-based study of cardiovascular disease risk factors, is the inclusion of many black persons. The black participants included in the ARIC Study reside principally in Jackson, Miss, with a few in North Carolina. The white participants in the ARIC Study reside in North Carolina, Maryland, and Minnesota. The size of the ARIC Study population and the standardization of methods across centers provide strengths

2 METHODS STUDY POPULATION The ARIC Study is a prospective study of risk factors for CHD and carotid atherosclerosis in men and women in 4 communities in the United States. 28 Participants aged 45 to 64 years were examined and followed up in Forsyth County, North Carolina; Jackson; suburban areas of Minneapolis, Minn; and Washington County, Maryland. Each study site selected a representative sample from its entire community population, with the exception of Jackson, where a representative sample only of black persons was selected. Race was self-reported. Communities in Maryland and Minnesota had fewer than 1% black persons; Forsyth County had 12% black persons. 29 From 1987 to 1989, community residents were recruited and participated in an examination that included interviews; an electrocardiogram (ECG); pulmonary function tests; blood drawn for measurements of lipid levels, lipoprotein levels, hemostatic factors, and chemistries; and a noninvasive B-mode ultrasonographic measurement of the intimal medial thickness (IMT) of the extracranial carotid arteries Approximately 46% of eligible participants in Jackson and 66% in the other 3 communities were examined. Subsequent examinations took place from 1990 to 1992, from 1993 to 1995, and from 1996 to STUDY VARIABLES Each Field Center of the ARIC Study received the approval of its Institutional Review Board before initiation. At the baseline visit, the study was explained to each prospective participant, and each participant was then required to read and sign a detailed informed consent document. Blood samples were collected following a fast of at least 8 hours. Methods for blood collection and for centralized measurement of plasma total cholesterol, triglyceride, HDL cholesterol, calculated LDL cholesterol, and glucose levels have been reported elsewhere. 28,31-34 Estimates of intraindividual variability in blood measurements have been reported Prevalent diabetes mellitus was defined as a fasting glucose level of 126 mg/dl or more ( 7.0 mmol/l), a nonfasting level of 200 mg/dl or more ( 11.1 mmol/l), a self-reported physician diagnosis of diabetes mellitus, or pharmacologic treatment for diabetes mellitus. Controlled diabetes mellitus was defined as a fasting glucose level of less than 130 mg/dl ( 7.2 mmol/l) among those classified as diabetic. Methods have been reported for ascertainment of body mass index (BMI) (calculated as weight in kilograms divided by the square of height in meters) and resting systolic blood pressure (SBP) and diastolic blood pressure (DBP). 28 Weight was measured with the participant wearing a scrub suit and no shoes. Obesity was defined as a BMI of 30 or higher, overweight as a BMI of 25 or higher and less than 30, and lean as a BMI of less than 25. Prevalent hypertension was defined as an SBP of 140 mm Hg or higher, a DBP of 90 mm Hg or higher, or selfreported use of antihypertensive medications in the past 2 weeks. Controlled hypertension was defined as an SBP lower than 140 mm Hg and a DBP lower than 90 mm Hg among those classified as hypertensive. Participants were defined as current smokers, ex-smokers, or never smokers, and pack-years of cigarettes smoked and current ethanol consumption (measured in grams per week) were estimated from interview. Educational level was defined as low for those who did not complete high school. Mid education was defined as a high school graduate and possibly some vocational school. High education was defined as at least some college. Procedures for determining anklebrachial index 38 and estimating ECG left ventricular hypertrophy (LVH) 39 have been previously published. Peripheral arterial disease was defined as an ankle-brachial index of less than 0.85 for women and less than 0.90 for men. Prevalent CHD at baseline was defined, for exclusion, as a self-reported history of a physician-diagnosed heart attack, evidence of a prior myocardial infarction by ECG, or self-report of cardiovascular surgery or coronary angioplasty. Bilateral B-mode ultrasonographic examinations of the carotid arteries were performed at 3 sites: the distal 10 mm of the common carotid artery, the bifurcation, and the proximal 10 mm of the internal carotid artery. Ultrasonographers were trained at the ARIC Study s Ultrasound Reading Center and certified annually. Measurements were made from videotapes at the reading center without knowledge of any characteristics of the participants. The analysis uses the combined intima plus media thickness (IMT), defined as the average distance between lumenintimal and media-adventitial interfaces measured at 1-mm intervals along the artery s longitudinal axis. The average of all measurements at all 6 arterial sites was used to represent the total extent of carotid thickening. Missing sites were imputed using maximum likelihood. Only far-wall measurements (deep to the skin) were used, given their greater accuracy. Abnormal IMT was defined as a thickness greater than 1 mm. ASCERTAINMENT OF INCIDENT EVENTS Coronary heart disease incident events were ascertained by contacting participants annually, identifying hospitalizations and deaths during the previous year, and surveying discharge lists from local hospitals and death certificates from State Vital Statistics Offices for potential cardiovascular events from 1987 through Trained abstractors obtained hospital medical records, recorded presenting symptoms and cardiac enzyme levels, and photocopied up to 3 ECGs for each person. The ECGs were coded using Minnesota Code at the University of Minnesota. Out-of-hospital deaths were investigated by death certificates and, in most cases, by an interview with one or more next of kin and a questionnaire filled out by the patient s physician. Coroner reports or autopsy reports, when available, were obtained. Details on quality assurance for ascertainment and classification of events have been published. 40,41 A CHD incident event was defined as a validated definite or probable hospitalized myocardial infarction, a definite CHDrelated death, an unrecognized myocardial infarction detected by comparison of triennial ARIC Study examination ECG with baseline ECG, or a CHD-related revascularization (surgery, angioplasty, stenting, or any combination of these). 40,41 The criteria for definite or probable hospitalized myocardial infarction were based on combinations of chest pain symptoms, ECG changes, and cardiac enzyme levels. The criteria for definite fatal CHD were based on chest pain symptoms, medical history, and underlying cause of death from the death certificate. A Morbidity and Mortality Classification Committee reviewed potential clinical events and determined the final diagnosis. Unrecognized incident myocardial infarction was determined from ECGs obtained at the 4 ARIC Study visits (a new major Q wave, a minor Q wave with ischemic ST-T changes, or a myocardial infarction by computerized NOVACODE 42 criteria, confirmed by a sideby-side visual comparison of baseline and follow-up ECGs). DATA ANALYSIS From the ARIC Study participants, we excluded the nonwhite persons in Minneapolis and Washington County and participants in Forsyth County who were neither black nor white (103 persons total). An additional 763 were excluded for prevalent CHD at baseline, 339 others for unknown status regarding prevalent CHD, and 525 for missing information on the risk 2566

3 factors of interest in this analysis. That left individuals (2298 black women, 5686 white women, 1396 black men, and 4682 white men) for analysis. For descriptive purposes, age-adjusted means or proportions (adjusted to the mean age of the entire sample, 54 years) of baseline risk factors were calculated by race, sex, and incident disease status by analysis of covariance methods for linear or logistic regression. 43 Crude race- and sex-specific cumulative incident CHD rates were calculated as number of events divided by cumulative follow-up time, and age-adjusted rates and their 95% confidence intervals (CIs) were computed from Poisson regression by analysis of covariance methods overall and by risk factor level. 43,44 For each risk factor considered, ageadjusted hazard rate ratios (HRRs) and their 95% CIs were computed by Cox proportional hazards regression, comparing putative higher risk levels with lowest risk level for categorical risk factors. 45 Continuous risk factors were categorized by standard cut points or by overall population tertiles, or HRRs were presented for a 1-SD difference in risk factor level. Multivariableadjusted HRRs were derived from Cox proportional hazards regression models including age, continuous LDL and HDL cholesterol levels, current and former smoking, hypertension, and diabetes mellitus, with or without educational level. RESULTS For the most part, participants who developed CHD had more adverse age-adjusted mean baseline risk factor levels than those who did not develop CHD in all race-sex groups. However, 95% CIs overlapped for cases and noncases for SBP and DBP for black men, for DBP for white women, for cigarette pack-years for black women and black men, and for BMI for all race-sex groups except white women (data available at: Most categorical CHD risk factors and atherosclerosis markers also were more favorable in noncases than in incident cases. Former smoking status, midlevel education, controlled hypertension, and controlled diabetes mellitus generally were not significantly different in any race-sex groups, nor was ECG LVH in white women or men. The absolute difference between cases and noncases was especially large for hypertension in black women (data available at: Table 1 shows age-adjusted 1987 to 1997 CHD incidence rates by race, sex, and risk level. Overall incidence rates were substantially higher in men than women for black and white persons. Sex differences in black persons were less than in white persons. Racial differences in overall incidence rates tended to be small when the standard ARIC Study CHD event definition was used. When revascularization procedures were excluded from the CHD event definition, rates were substantially lower in white persons, but changed little for black persons. Coronary heart disease incidence rates were higher in hypertensive than nonhypertensive persons for all racesex groups, but, interestingly, the incidence for nonhypertensive black persons was lower than for white persons. Incidence rates were significantly higher for elevated LDL cholesterol levels for white men and women but not for black men and women. s were higher for those with a low (vs high) HDL cholesterol level in all racesex groups. s were significantly higher for diabetic than nondiabetic persons. Incidence rates were higher in current smokers than in never smokers for all racesex groups. Incidence rates were higher in those with lower vs the highest educational level. s were substantially higher in black women with ECG LVH compared with those without ECG LVH. s were higher in all groups for those with a low vs a high anklebrachial index or with a high vs a low carotid IMT. Table 2 shows the age-adjusted HRRs for CHD considering each major risk factor one at a time. The relationship for hypertension was especially strong in black women, in part reflecting the low rate in the nonhypertensive black women (Table 1), but was statistically significant in all race-sex groups. Systolic blood pressure was significantly and positively associated with CHD in all groups except black men. Diastolic blood pressure was significant only in black women and white men. For LDL cholesterol level, the relation with CHD was strong, positive, and statistically significant for all groups. For HDL cholesterol level, the inverse relationship was statistically significant in all groups. Diabetes mellitus was a significant risk factor in all groups, especially white women. Current smoking was an especially strong predictor of CHD in women, and was statistically significant in all groups. Body mass index was weakly predictive of CHD in all but black men. Graduating from high school, compared with less education, was associated with a reduced CHD risk in all groups except black men. An educational level that included some college was associated with a lower CHD risk in all groups. Electrocardiographic LVH was an especially strong risk factor in black women, was statistically significant in black men, and was not significant for white men or women. Peripheral arterial disease, measured by anklebrachial ratio of SBP ( 0.85 for women and 0.90 for men), was a strong risk indicator in all race-sex groups. Carotid IMT was predictive in all groups, but marginally so in black men. Table 3 shows multivariable-adjusted HRRs for CHD. All variables from Table 2 that remained statistically significantly associated with CHD for all race-sex groups in the multivariable model included hypertension, LDL cholesterol level, HDL cholesterol level, diabetes mellitus, and current smoking. Current smoking seemed to be a stronger predictor of CHD in women than in men. Hypertension was a particularly strong predictor in black women (HRR, 4.8; P=.02 for difference by race) than in other groups. Diabetes mellitus seemed to be a stronger predictor in white women (HRR, 3.3; P=.03 for difference by race) than in other groups. The HDL cholesterol level was a stronger predictor in white men than in black men (P=.04). When educational level was added to the model shown in Table 3, the associations of the other risk factors with CHD changed little. The associations for education variables, however, were weaker than those shown in Table 2. There still was an independent association of CHD with a high vs a low level of education for black men (HRR, 0.6; 95% CI, ) and white women (HRR, 0.7; 95% CI, ) and possibly for black women (HRR, 0.7; 95% CI, ), but not for white men (HRR, 0.9; 95% CI, ). 2567

4 Table 1., Number of, and Age-Adjusted Incidence s per 1000 Person-Years of CHD by Race, Sex, and Risk Level* Women Men Risk Factors Black White Black White All ( ) ( ) ( ) ( ) All (revised) ( ) ( ) ( ) ( ) Hypertension Yes ( ) ( ) ( ) ( ) No ( ) ( ) ( ) ( ) LDL cholesterol level, mg/dl (mmol/l) 160 ( 4.14) ( ) ( ) ( ) ( ) 160 ( 4.14) ( ) ( ) ( ) ( ) HDL cholesterol level, mg/dl (mmol/l) 35 ( 0.91) ( ) ( ) ( ) ( ) 35 ( 0.91) ( ) ( ) ( ) ( ) Diabetes mellitus Yes ( ) ( ) ( ) ( ) No ( ) ( ) ( ) ( ) Smoker Current ( ) ( ) ( ) ( ) Former ( ) ( ) ( ) ( ) Never ( ) ( ) ( ) ( ) Weight Obese ( ) ( ) ( ) ( ) Overweight ( ) ( ) ( ) ( ) Lean ( ) ( ) ( ) ( ) Educational level Low ( ) ( ) ( ) ( ) Mid ( ) ( ) ( ) ( ) High ( ) ( ) ( ) ( ) ECG LVH Yes ( ) ( ) ( ) ( ) No ( ) ( ) ( ) ( ) ABI Low ( ) ( ) ( ) ( ) Not low ( ) ( ) ( ) ( ) IMT High ( ) ( ) ( ) ( ) Not high ( ) ( ) ( ) ( ) *CHD indicates coronary heart disease; CI, confidence interval; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ECG, electrocardiographic; LVH, left ventricular hypertrophy; ABI, ankle-brachial index; and IMT, intimal medial thickness. Includes CHD events, excluding revascularization procedures. COMMENT This study has several key findings. By using the standard ARIC Study definition that includes coronary revascularization, the incidence rates of CHD were similar in black and white persons, although there were somewhat higher rates in black women than white women and slightly lower rates in black men than white men. When revascularization procedures were excluded, rates for black men and women changed little, but rates were substantially lower for white men and women. These data confirm lower use of revascularization procedures in black compared with white persons and suggest possible underestimation of incident CHD in black persons or overestimation in white persons when revascularization procedures are included in the definition of CHD Traditional CHD risk factors in white populations were also associated with CHD in this population of black persons. However, black and white differences that have clinical significance in risk factor associations were noted. In particular, hypertension is a more powerful predictor in black women than in other race-sex groups. Diabetes mellitus was a weaker predictor in black women than in white women. Reported racial/ethnic differences in CHD incidence are not entirely consistent Most recent reports suggest similar incidence rates for black and white men and higher rates for black than for white women. Reports 49,50 of CHD- 2568

5 Table 2. Age-Adjusted HRRs for CHD From 1 Risk Factor Cox Proportional Hazards Models, by Race and Sex* HRR Women Men Risk Factors (Increment) Black White Black White Hypertension 5.3 ( ) 2.7 ( ) 2.0 ( ) 1.8 ( ) Systolic BP (1 SD) 1.7 ( ) 1.4 ( ) 1.1 ( ) 1.3 ( ) Diastolic BP (1 SD) 1.4 ( ) 1.0 ( ) 1.0 ( ) 1.1 ( ) LDL cholesterol level (1 SD) 1.3 ( ) 1.4 ( ) 1.2 ( ) 1.4 ( ) HDL cholesterol level (1 SD) 0.6 ( ) 0.5 ( ) 0.7 ( ) 0.5 ( ) Diabetes mellitus 2.3 ( ) 5.1 ( ) 1.7 ( ) 2.4 ( ) Current smoker vs never smoker 2.6 ( ) 2.9 ( ) 1.7 ( ) 1.8 ( ) Former smoker vs never smoker 1.0 ( ) 1.0 ( ) 0.8 ( ) 1.3 ( ) BMI (1 SD) 1.2 ( ) 1.2 ( ) 1.0 ( ) 1.1 ( ) Educational level Mid vs low 0.5 ( ) 0.7 ( ) 0.9 ( ) 0.9 ( ) High vs low 0.5 ( ) 0.4 ( ) 0.6 ( ) 0.7 ( ) ECG LVH 5.9 ( ) 2.2 ( ) 2.0 ( ) 1.6 ( ) Low ABI 3.5 ( ) 3.9 ( ) 4.9 ( ) 2.8 ( ) IMT 1 mm 3.1 ( ) 4.3 ( ) 1.7 ( ) 2.3 ( ) *HRR indicates hazard rate ratio; CHD, coronary heart disease; CI, confidence interval; BP, blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI, body mass index; ECG, electrocardiographic; LVH, left ventricular hypertrophy; ABI, ankle-brachial index; and IMT, intimal medial thickness. Values are less than 0.85 for women and less than 0.90 for men. Table 3. Adjusted HRRs for CHD From Multivariable Cox Proportional Hazards Models for a Given Difference in Risk Factor Level, by Race and Sex* HRR Women Men Risk Factors (Increment) Black White Black White Hypertension 4.8 ( ) 2.1 ( ) 2.0 ( ) 1.6 ( ) LDL cholesterol level (1 SD) 1.3 ( ) 1.3 ( ) 1.2 ( ) 1.4 ( ) HDL cholesterol level (1 SD) 0.8 ( ) 0.6 ( ) 0.8 ( ) 0.6 ( ) Diabetes mellitus 1.8 ( ) 3.3 ( ) 1.6 ( ) 2.0 ( ) Current smoker vs never smoker 2.6 ( ) 3.0 ( ) 1.9 ( ) 1.7 ( ) Former smoker vs never smoker 1.0 ( ) 1.2 ( ) 0.8 ( ) 1.3 ( ) *Adjusted for age and the other variables in the model (hypertension, LDL cholesterol level, HDL cholesterol level, diabetes mellitus, and smoking status). HRR indicates hazard rate ratio; CHD, coronary heart disease; CI, confidence interval; LDL, low-density lipoprotein; and HDL, high-density lipoprotein. related mortality (as opposed to CHD incidence) in the ARIC Study and elsewhere often demonstrate higher rates for black than for white men. There are several reasons why black-white ratios may be higher for CHD-related mortality vs CHD incidence. One of the most important of these is the underestimation of true rates in black persons or the overestimation of true rates in white persons of incident cases because of lower procedure rates in black persons, as previously noted. Also, case fatality rates for CHD are higher in black than in white persons, contributing to higher mortality rates for black men. 46 Misclassification of cause of death may contribute to inflation of the numerator in incidence rates for black persons in some evaluations. Undercounting black men in the census may account for underestimation of the denominator for some populations, thereby inflating mortality rates. In our study, and in others, 51 hypertension was a particularly powerful risk factor for CHD in black persons, especially in women. High HRRs for hypertension in black women seem to be explained by a relatively low CHD rate in those without hypertension. The CHD incidence rate for black women without hypertension was 1.6 ( ) per 1000 person-years vs 2.9 ( ) for white women. The CHD incidence rate for black women with hypertension was 7.6 ( ); and for white women with hypertension, 7.5 ( ). If replicated, understanding why normotensive black women are at such low risk may lead to a better understanding of how to prevent CHD in others. Another potential explanation might be that black women with hypertension have a higher blood pressure or a longer duration of hypertension than comparative groups. In this and some other studies, 2,51 diabetes mellitus was a weaker predictor of CHD in black than in white persons. Higher HRRs for white women with diabetes mellitus seem to be accounted for by excess CHD events in this group compared with nondiabetic persons. Table 1 shows an age-adjusted CHD incidence rate of 15.7 ( ) per 1000 person-years for white women with diabetes mellitus compared with 9.3 ( ) for black women. s for nondiabetic persons were similar (3.2 and 4.0, respectively). 2569

6 Higher risk coupled with a much higher prevalence of hypertension than in white persons 52 causes the population-attributable risk of CHD for hypertension to be much higher in black persons (black women, 68.0%; and black men, 34.6%) than in white persons (white women, 21.6%; and white men, 13.4%). The higher prevalence of obesity in black women accounts for part of this high prevalence of hypertension, 53 although BMI was not itself a strong risk factor for CHD in our age-adjusted analysis. As with hypertension, though, the much higher prevalence of diabetes mellitus in black than in white persons makes the population-attributable risk for diabetes mellitus comparable for black persons (black women, 13.6%; and black men, 9.1%) and white persons (white women, 14.2%; and white men, 8.0%), despite the lower HRR associated with diabetes mellitus in black persons. 2 Another potential explanation for different HRRs for diabetes mellitus and hypertension between black and white persons is the rate of control of these risk factors to standard values, as noted in guidelines. Control rates for diabetes mellitus were poor in all groups, but more so in black men and women (data available at: Yet, the patterns of control across race-sex groups are not consistent with the CHD HRRs related to diabetes mellitus and hypertension, suggesting that poorer control rates do not account for racial differences in HRRs. Plasma lipid levels were associated with carotid IMT more strongly in white than in black persons in the ARIC Study cohort. 54 However, in this analysis using incident CHD as the outcome, LDL cholesterol level was almost as strong a predictor in black as in white persons. Highdensity lipoprotein cholesterol level seemed less predictive in black than in white persons. Socioeconomic status is inversely associated with CHD 13,55-58 and often remains predictive independent of other CHD risk factors. Some of the black-white difference in health problems is attenuated by adjustment for socioeconomic status. 51 Yet, it has been argued that it is impossible to completely adjust for socioeconomic status using traditional measures. 15 In the multivariable model of risk, educational level was an independent predictor of CHD in white women and black men, and its inclusion in regression models had almost no impact on the predictability of other risk factors. There are several limitations of this study and data analysis. Relatively low response rates, especially in Jackson, suggest that incidence rates may be overestimated or underestimated. 29,59 Those with lower educational levels were less likely to participate and more likely to have a higher CHD risk. This most likely would underestimate incidence in black compared with white persons in this cohort. Also, in a population with a high disease burden occurring relatively early in life, such as in the Jackson cohort, confounding by comorbidity is challenging. Coronary heart disease incidence certainly is impacted by early deaths from other illnesses, including other cardiovascular diseases such as stroke. Another limitation of this analysis is the challenge of generalizability of the Jackson cohort to black persons living outside Jackson. Other limitations include those often associated with large, prospective, observational studies, although unavailability for follow-up was minimal in this study. Although many participants did not participate in clinic examinations 2 to 4, fewer than 4% have been unavailable for surveillance follow-up during the period of this study, and all risk factor variables used for analysis were based on baseline examination data. Despite great effort to minimize measurement errors, in large multicenter studies, this possibility is always a limitation. The relatively small sample size and the small number of events in black men is a recognized limitation. Expansion of this cohort and continued surveillance through the Jackson Heart Study 18 will aid in future analysis. To our knowledge, this study provides the largest cohort of black persons in a prospective population study with carefully verified events. The Charleston Heart Study and the Evans County Heart Study have longer follow-up periods reported, but are restricted to fatal events and based on smaller cohorts of black persons from an earlier generation. 6,7 Other studies have reported CHD-related mortality 13 or unvalidated CHD incidence. 9,14 Racial differences noted in the ARIC Study must be interpreted with caution, because almost all of the black persons were in one geographic location Jackson. Mississippi s rates of CHD and stroke are among the highest in the nation in all race-sex groups. 19 Most of the major findings in this report, however, confirm findings 5-14 for black persons in other locations. The smaller sample size of black men and the limited number of events present a problem of power in demonstrating associations. In some instances, the failure to show a relationship for a given risk factor may be due to limited power. Expansion of the Jackson cohort and a longer follow-up period should help confirm or expand these initial findings. 1 In summary, CHD incidence in the ARIC Study was similar in black and white men and marginally higher in black women than in white women using standard definitions. Excluding revascularization procedures from the definition of CHD events revealed higher rates in black than in white persons, for men and women. The traditional risk factors were associated with CHD incidence in black persons, as in white persons. Hypertension seemed to be a more potent predictor, and diabetes mellitus less predictive, in black than in white persons. Findings from this study, along with clinical trial evidence showing efficacy, support aggressive management of traditional risk factors in black persons, as in white persons. Particularly, the study supports aggressive management of hypertension in black women. Understanding the intriguing racial differences in risk factor prediction may be an important part of further elucidating the causes of CHD and may lead to better methods of preventing and treating CHD. Accepted for publication April 3, The ARIC Study is a collaborative study supported by contracts N01-HC-55015, N01-HC-55016, N01-HC , N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC from the National Heart, Lung, and Blood Institute. We thank the staff and participants in the ARIC Study for their important contributions. 2570

7 Corresponding author and reprints: Daniel W. Jones, MD, Division of Hypertension, Department of Medicine, The University of Mississippi Medical Center, 2500 N State St, Jackson, MS ( djones@ovc.umsmed.edu). REFERENCES 1. Kannel WB, Castelli WP, Gordon T, et al. Serum cholesterol, lipoproteins and the risk of coronary heart disease. Ann Intern Med. 1971;74: Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. Diabetes Care. 1997;20: Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, Am J Epidemiol. 1997; 146: Wilson PWF, D Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: Keil JE, Sutherland SE, Hames CG, et al. Coronary disease mortality and risk factors in black and white men. Arch Intern Med. 1995;155: Keil JE, Sutherland SE, Knapp RB, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med. 1993;329: Johnson JL, Heineman EF, Heiss G, Hames CG, Tyroler HA. Cardiovascular disease risk factors and mortality among black women and white women aged years in Evans County, Georgia. Am J Epidemiol. 1986;123: Liao Y, McGee DL, Cooper RS. Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts. Am J Cardiol. 1999; 84: Otten MW Jr, Teutsch SM, Williamson DF, Marks JS. The effect of known risk factors on the excess mortality of black adults in the United Sates. JAMA. 1990; 263: Gillum RF. Risk factors for strokes in blacks: a critical review. Am J Epidemiol. 1999;150: Gillum RF, Mussolino ME, Madans JH. Coronary heart disease risk factors and attributable risks in African-American women and men: NHANES I epidemiologic follow-up study. Am J Public Health. 1998;88: Gillum RF, Mussolino ME, Madans JH. Coronary heart disease incidence and survival in African-American women and men: the NHANES I epidemiologic follow-up study. Ann Intern Med. 1997;127: Smith GD, Neaton JD, Wentworth D, Stamler R, Stamler J, for the MRFIT Research Group. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. Lancet. 1998;351: Rosenberg L, Palmer JR, Rao RS, Adams-Campbell LL. Risk factors for coronary heart disease in African American women. Am J Epidemiol. 1999;150: Race, genes, and causal inference: a statement of opinion. Epidemiology and Prevention Newsletter. Spring 2000: Howard BV. How do we evaluate and utilize data on ethnic differences? Ann Epidemiol. 1999;9: Muntaner C, Nieto FJ, O Campo R. Additional clarification re: The Bell curve: on race, social class, and epidemiologic research. Am J Epidemiol. 1997;146: Sempos CT, Bild DW, Manolio TA. Overview of the Jackson Heart Study: a study of cardiovascular diseases in African American men and women. Am J Med Sci. 1999;317: Jones DW, Sempos CT, Thom TJ, et al. Rising levels of cardiovascular mortality in Mississippi, Am J Med Sci. 2000;319: Gillum RF. Cardiovascular disease in the United States: an epidemiologic overview. In: Saunders E, ed. Cardiovascular Diseases in Blacks. Philadelphia, Pa: FA Davis Co Publishers; 1991: Gillum RF. The epidemiology of cardiovascular disease in black Americans. N Engl J Med. 1996;335: Sempos C, Cooper R, Kovar MG, et al. Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health. 1988;78: Liao Y, Cooper RS. Continued adverse trends in coronary heart disease mortality among blacks, Public Health Rep. 1995;110: National Heart, Lung, and Blood Institute. NHLBI Morbidity and Mortality Chartbook (1996). Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health, US Dept of Health and Human Services; Cooper R, Sempos C, Hsieh SC, et al. Slowdown of the decline in stroke mortality in the United States, Stroke. 1990;21: Gillum RF, Sempos CT. The end of the long-term decline in stroke mortality in the United States? Stroke. 1997;28: Pickle LW, Mugiole M, Jones GK, et al. Atlas of United States Mortality. Hyattsville, Md: National Center for Health Statistics; December DHHS publication (PHS) H The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129: Jackson R, Chambless LE, Yang K, et al, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;49: Bond MG, Barnes RW, Riley WA, et al. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimaging. 1991;1: Papp AC, Hatzakis H, Bracey A, et al. ARIC hemostasis study, I: development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;71: National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study: Operations Manual, No. 7: Blood Collection and Processing: Version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina at Chapel Hill; National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study: Operations Manual, No. 8: Lipid and Lipoprotein Determinations: Version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina at Chapel Hill; Siedel J, Hegele EO, Ziegenhorn J, et al. Reagent for the enzymatic determination of total serum cholesterol with improved lipolytic efficiency. Clin Chem. 1983; 29: Eckfeldt J, Chambless LE, Shen Y-L. Short-term, within-person variability in clinical chemistry test results: experiences from the Atherosclerosis Risk in Communities (ARIC) Study. Arch Pathol Lab Med. 1994;118: Chambless LE, McMahon R, Wu K, et al. Short-term intra-individual variability in hemostasis factors: the ARIC Study. Ann Epidemiol. 1992;2: Chambless LE, McMahon RP, Brown SA, et al. Short-term intra-individual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992;136: Mundt KA, Chambless LE, Burnham CB, Heiss G. Measuring ankle systolic blood pressure and validation of the Dinamap 1846 sx. Angiology. 1992;43: Arnett DK, Rautaharju P, Crow R, et al. Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC Study). Am J Cardiol. 1994;74: White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years experience. J Clin Epidemiol. 1996;49: National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study: Operations Manual, No. 3: Surveillance Component Procedures: Version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina at Chapel Hill; Rautaharju PM, Warren WJ, Jain U, et al. Myocardial infarction injury score: an electrocardiographic coding scheme for ischemic heart disease. Circulation. 1981; 64: Wilcosky T, Chambless LE. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chronic Dis. 1985;38: Kleinbaum D, Kupper L, Muller K. Applied Regression Analysis and Other Multivariate Regression Methods. 2nd ed. Boston, Mass: PSW-KENT Publishing Co; Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons Inc; Francis CK. Research in coronary heart disease in blacks: issues and challenges. J Health Care Poor Underserved. 1997;8: Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med. 2001;135: Schneider EC, Leape LL, Weissman JS, Piana RN, Gatsonis C, Epstein AM. Racial differences in cardiac revascularization rates: does overuse explain higher rates among white patients? Ann Intern Med. 2001;135: Trends in ischemic heart disease death rates for blacks and whites: United States, MMWR Morb Mortal Wkly Rep. 1998;47: Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to N Engl J Med. 1998;339: Potts JL, Thomas J. Traditional coronary risk factors in African Americans. Am J Med Sci. 1999;317: Hutchinson RG, Watson RL, Davis CE, et al. Racial differences in risk factors for atherosclerosis: the ARIC Study. Angiology. 1997;48: Jones DW. What is the role of obesity in hypertension and target organ injury in African Americans? Am J Med Sci. 1999;317: Sorlie PD, Sharrett AR, Patsch W, et al. The relationship between lipids/lipoproteins and atherosclerosis in African Americans and whites: the Atherosclerosis Risk in Communities Study. Ann Epidemiol. 1999;9: Harrell JS, Gore SV. Cardiovascular risk factors and socioeconomic status in African American and Caucasian women. Res Nurs Health. 1998;21: Metcalf PA, Sharrett AR, Folsom AR, et al. African American white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1998;148: Feldman JJ, Makuc DM, Kleinman JC, Cornoni-Huntley J. National trends in educational differentials in mortality. Am J Epidemiol. 1989;129: Escobedo LG, Giles WH, Anda RF. Socioeconomic status, race, and death from coronary heart disease. Am J Prev Med. 1997;13: Shahar E, Folsom AR, Jackson R. The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Ann Epidemiol. 1996;6:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort

More information

CONSIDERABLE STRIDES HAVE

CONSIDERABLE STRIDES HAVE ORIGINAL INVESTIGATION Comparison of Risk Factors for Cardiovascular Mortality in Black and White Adults Mercedes R. Carnethon, PhD; Elizabeth B. Lynch, PhD; Alan R. Dyer, PhD; Donald M. Lloyd-Jones, MD,

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

atherosclerosis; carotid arteries; cohort studies; risk factors MATERIALS AND METHODS Cohort examination

atherosclerosis; carotid arteries; cohort studies; risk factors MATERIALS AND METHODS Cohort examination American Journal of Epidemiology Copyright 2002 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 155, No. 1 Printed in U.S.A. Risk Factors for Progression of Atherosclerosis

More information

American Journal of Epidemiology Advance Access published April 16, 2009

American Journal of Epidemiology Advance Access published April 16, 2009 American Journal of Epidemiology Advance Access published April 16, 2009 American Journal of Epidemiology ª The Author 2009. Published by the Johns Hopkins Bloomberg School of Public Health. All rights

More information

Type 2 diabetes is a significant risk factor for coronary

Type 2 diabetes is a significant risk factor for coronary Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction Chong Do Lee, EdD; Aaron R. Folsom, MD; James S. Pankow, PhD; Frederick L. Brancati, MD; For the

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

YOUNG ADULT MEN AND MIDDLEaged

YOUNG ADULT MEN AND MIDDLEaged BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,

More information

ORIGINAL INVESTIGATION. Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease

ORIGINAL INVESTIGATION. Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease ORIGINAL INVESTIGATION Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease Lynn E. Eberly, PhD; Jeremiah Stamler, MD; James D. Neaton, PhD; for the Multiple

More information

ARIC Manuscript Proposal # PC Reviewed: 05/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 05/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1508 PC Reviewed: 05/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hemostatic markers and risk of atrial fibrillation: the Atherosclerosis Risk

More information

Diabetes and Decline in Heart Disease Mortality in US Adults JAMA. 1999;281:

Diabetes and Decline in Heart Disease Mortality in US Adults JAMA. 1999;281: ORIGINAL CONTRIBUTION and Decline in Mortality in US Adults Ken Gu, PhD Catherine C. Cowie, PhD, MPH Maureen I. Harris, PhD, MPH MORTALITY FROM HEART disease has declined substantially in the United States

More information

Journal of the American College of Cardiology Vol. 57, No. 16, by the American College of Cardiology Foundation ISSN /$36.

Journal of the American College of Cardiology Vol. 57, No. 16, by the American College of Cardiology Foundation ISSN /$36. Journal of the American College of Cardiology Vol. 57, No. 16, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.11.041

More information

The Framingham Risk Score (FRS) is widely recommended

The Framingham Risk Score (FRS) is widely recommended C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore

More information

Analyzing Coronary Heart Disease Risk Factors and Proper Clinical Prescription of Statins. Peter Thorne

Analyzing Coronary Heart Disease Risk Factors and Proper Clinical Prescription of Statins. Peter Thorne Abstract Analyzing Coronary Heart Disease Risk Factors and Proper Clinical Prescription of Statins Peter Thorne A sample of adults participating in the first 7 months of visit 5 of the Atherosclerosis

More information

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

Much of the United States adult population is at risk of

Much of the United States adult population is at risk of Absolute and Attributable Risks of Heart Failure Incidence in Relation to Optimal Risk Factors Aaron R. Folsom, MD; Kazumasa Yamagishi, MD, PhD; Atsushi Hozawa, MD, PhD; Lloyd E. Chambless, PhD; for the

More information

the U.S. population, have some form of cardiovascular disease. Each year, approximately 6 million hospitalizations

the U.S. population, have some form of cardiovascular disease. Each year, approximately 6 million hospitalizations Cardioprotection: What is it? Who needs it? William B. Kannel, MD, MPH From the Department of Preventive Medicine and Epidemiology, Evans Department of Clinical Research, Boston University School of Medicine,

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Cardiovascular Disease Prevention: Current Knowledge, Future Directions Cardiovascular Disease Prevention: Current Knowledge, Future Directions Daniel Levy, MD Director, Framingham Heart Study Professor of Medicine, Boston University School of Medicine Editor-in-Chief, Journal

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 1998, by the Massachusetts Medical Society VOLUME 339 S EPTEMBER 24, 1998 NUMBER 13 TRENDS IN THE INCIDENCE OF MYOCARDIAL INFARCTION AND IN MORTALITY DUE

More information

Rehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD

Rehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,

More information

Clinical significance of a high ankle-brachial index: Insights from the Atherosclerosis Risk in Communities (ARIC) Study

Clinical significance of a high ankle-brachial index: Insights from the Atherosclerosis Risk in Communities (ARIC) Study Atherosclerosis 190 (2007) 459 464 Clinical significance of a high ankle-brachial index: Insights from the Atherosclerosis Risk in Communities (ARIC) Study Keattiyoat Wattanakit a, Aaron R. Folsom a, Daniel

More information

Importance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease

Importance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease Importance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease Arch G. Mainous, III, PhD, Charles J. Everett, PhD, Marty S. Player, MD, MS, Dana E. King, MD,

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey

Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey 1-28 Antihypertensive Drug Therapy and Survival by Treatment Status in a National Survey Richard J. Havlik, Andrea Z. LaCroix, Joel C. Kleinman, Deborah D. Ingram, Tamara Harris, and Joan Cornoni-Huntley

More information

Intima-Media Thickness

Intima-Media Thickness European Society of Cardiology Stockholm, 30th August 2010 Intima-Media Thickness Integration of arterial assessment into clinical practice Prof Arno Schmidt-Trucksäss, MD Institute of Exercise and Health

More information

PAPER Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study

PAPER Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study (2002) 26, 58 64 ß 2002 Nature Publishing Group All rights reserved 0307 0565/02 $25.00 www.nature.com/ijo PAPER Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis

More information

Why Do We Treat Obesity? Epidemiology

Why Do We Treat Obesity? Epidemiology Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population

More information

Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction

Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction Journal of the American College of Cardiology Vol. 48, No. 6, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.05.047

More information

CLINICAL STUDY. Yasser Khalil, MD; Bertrand Mukete, MD; Michael J. Durkin, MD; June Coccia, MS, RVT; Martin E. Matsumura, MD

CLINICAL STUDY. Yasser Khalil, MD; Bertrand Mukete, MD; Michael J. Durkin, MD; June Coccia, MS, RVT; Martin E. Matsumura, MD 117 CLINICAL STUDY A Comparison of Assessment of Coronary Calcium vs Carotid Intima Media Thickness for Determination of Vascular Age and Adjustment of the Framingham Risk Score Yasser Khalil, MD; Bertrand

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular

More information

Intensive Treatment of Diabetes is Associated with a Reduced Rate of Peripheral Arterial Calcification in Diabetes Control and Complications Trial

Intensive Treatment of Diabetes is Associated with a Reduced Rate of Peripheral Arterial Calcification in Diabetes Control and Complications Trial Diabetes Care Publish Ahead of Print, published online July 10, 2007 Intensive Treatment of Diabetes is Associated with a Reduced Rate of Peripheral Arterial Calcification in Diabetes Control and Complications

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carotid_intimal_medial_thickness 12/2006 10/2016 10/2018 10/2017 Description of Procedure or Service Ultrasonographic

More information

Page down (pdf converstion error)

Page down (pdf converstion error) 1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999

More information

Recently reported clinical trials have provided strong

Recently reported clinical trials have provided strong Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions The Atherosclerosis Risk in Communities (ARIC)

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Underdiagnosis of Sleep Apnea Syndrome in U.S. Communities

Underdiagnosis of Sleep Apnea Syndrome in U.S. Communities ORIGINAL ARTICLE Underdiagnosis of Sleep Apnea Syndrome in U.S. Communities Vishesh Kapur, M.D., 1 Kingman P. Strohl, M.D., 2 Susan Redline, M.D., M.P.H., 3 Conrad Iber, M.D., 4 George O Connor, M.D.,

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Coronary heart disease (CHD) is the leading cause of

Coronary heart disease (CHD) is the leading cause of Serum Albumin and Risk of Myocardial Infarction and All-Cause Mortality in the Framingham Offspring Study Luc Djoussé, MD, DSc; Kenneth J. Rothman, DrPH; L. Adrienne Cupples, PhD; Daniel Levy, MD; R. Curtis

More information

CARDIOVASCULAR RISK ASSESSMENT ADDITION OF CHRONIC KIDNEY DISEASE AND RACE TO THE FRAMINGHAM EQUATION PAUL E. DRAWZ, MD, MHS

CARDIOVASCULAR RISK ASSESSMENT ADDITION OF CHRONIC KIDNEY DISEASE AND RACE TO THE FRAMINGHAM EQUATION PAUL E. DRAWZ, MD, MHS CARDIOVASCULAR RISK ASSESSMENT ADDITION OF CHRONIC KIDNEY DISEASE AND RACE TO THE FRAMINGHAM EQUATION by PAUL E. DRAWZ, MD, MHS Submitted in partial fulfillment of the requirements for the degree of Master

More information

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive

More information

Original Research Article

Original Research Article A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH Diabetes Care Publish Ahead of Print, published online April 1, 2008 Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic Syndrome Khiet C. Hoang MD, Heli Ghandehari, BS, Victor

More information

ARIC Manuscript Proposal # 1518

ARIC Manuscript Proposal # 1518 ARIC Manuscript Proposal # 1518 PC Reviewed: 5/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Prevalence of kidney stones and incidence of kidney stone hospitalization in

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine

More information

The Impact of Smoking on Acute Ischemic Stroke

The Impact of Smoking on Acute Ischemic Stroke Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease

More information

High Density Lipoprotein Cholesterol and Mortality

High Density Lipoprotein Cholesterol and Mortality High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants

More information

The Second Report of the Expert Panel on Detection,

The Second Report of the Expert Panel on Detection, Blood Cholesterol Screening Influence of State on Cholesterol Results and Management Decisions Steven R. Craig, MD, Rupal V. Amin, MD, Daniel W. Russell, PhD, Norman F. Paradise, PhD OBJECTIVE: To compare

More information

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population! Myths, Heart Disease and the Latino Population Maria T. Vivaldi MD MGH Women s Heart Health Program Hispanics constitute 16.3 % of US population! 1 LEADING CAUSES OF DEATH IN LATINOS Heart disease is the

More information

Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness. The Carotid Atherosclerosis Progression Study

Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness. The Carotid Atherosclerosis Progression Study Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness The Carotid Atherosclerosis Progression Study Andrew D. Mackinnon, MRCP; Paula Jerrard-Dunne, MRCPI; Matthias

More information

Considerable evidence has been presented on the increased. Assessing Risk for Development of Diabetes in Young Adults

Considerable evidence has been presented on the increased. Assessing Risk for Development of Diabetes in Young Adults Assessing Risk for Development of Diabetes in Young Adults Arch G. Mainous III, PhD Vanessa A. Diaz, MD, MS Charles J. Everett, PhD Department of Family Medicine, Medical University of South Carolina,

More information

Chronic kidney disease (CKD) has received

Chronic kidney disease (CKD) has received Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:

More information

/13/$ - see front matter Ó 2013 Elsevier Inc. All rights reserved.

/13/$ - see front matter Ó 2013 Elsevier Inc. All rights reserved. Prognostic Value of Frontal QRS-T Angle in Patients Without Clinical Evidence of Cardiovascular Disease (from the Multi-Ethnic Study of Atherosclerosis) Joseph A. Walsh III, MD, MS a,b, Elsayed Z. Soliman,

More information

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes

Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,

More information

The New England Journal of Medicine CUMULATIVE EFFECTS OF HIGH CHOLESTEROL LEVELS, HIGH BLOOD PRESSURE, AND CIGARETTE SMOKING ON CAROTID STENOSIS

The New England Journal of Medicine CUMULATIVE EFFECTS OF HIGH CHOLESTEROL LEVELS, HIGH BLOOD PRESSURE, AND CIGARETTE SMOKING ON CAROTID STENOSIS CUMULATIVE EFFECTS OF HIGH CHOLESTEROL LEVELS, HIGH BLOOD PRESSURE, AND CIGARETTE SMOKING ON CAROTID STENOSIS PETER W.F. WILSON, M.D., JEFFREY M. HOEG, M.D., RALPH B. D AGOSTINO, PH.D., HALIT SILBERSHATZ,

More information

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease

American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease AMWA is a leader in its dedication to educating all physicians and their patients about heart disease,

More information

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease (2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk

More information

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction Clinical Investigation and Reports Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction The Rotterdam Study Irene M. van der Meer, MD, PhD; Michiel L. Bots, MD,

More information

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Diabetes Care 31: , 2008

Diabetes Care 31: , 2008 Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S. KHIET C. HOANG, MD HELI GHANDEHARI VICTOR

More information

Diabetologia 9 Springer-Verlag 1991

Diabetologia 9 Springer-Verlag 1991 Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease

More information

Type 2 diabetes and atherosclerotic cardiovascular

Type 2 diabetes and atherosclerotic cardiovascular Risk Factor Groupings Related to Insulin Resistance and Their Synergistic Effects on Subclinical Atherosclerosis The Atherosclerosis Risk in Communities Study Sherita Hill Golden, 1 Aaron R. Folsom, 2

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

Coronary artery disease (CAD) risk factors

Coronary artery disease (CAD) risk factors Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes

More information

ORIGINAL INVESTIGATION. Profile for Estimating Risk of Heart Failure

ORIGINAL INVESTIGATION. Profile for Estimating Risk of Heart Failure ORIGINAL INVESTIGATION Profile for Estimating Risk of Heart Failure William B. Kannel, MD, MPH; Ralph B. D Agostino, PhD; Halit Silbershatz, PhD; Albert J. Belanger, MS; Peter W. F. Wilson, MD; Daniel

More information

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

ARIC Manuscript Proposal # PC Reviewed: _12/20/05 Status: Priority: SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: _12/20/05 Status: Priority: SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1124 PC Reviewed: _12/20/05 Status: Priority: SC Reviewed: Status: Priority: 1.a. Full Title: The Effect of Using Framingham Risk Calculators with Different Predicted Outcomes

More information

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Age and the Burden of Death Attributable to Diabetes in the United States

Age and the Burden of Death Attributable to Diabetes in the United States American Journal of Epidemiology Copyright 2002 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 156, No. 8 Printed in U.S.A. DOI: 10.1093/aje/kwf111 Age and the Burden of

More information

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,

More information

The presence of cardiovascular disease risk factors, clinical

The presence of cardiovascular disease risk factors, clinical The Impact of JNC-VI Guidelines on Treatment Recommendations in the US Population Paul Muntner, Jiang He, Edward J. Roccella, Paul K. Whelton Abstract Using epidemiological and clinical trial evidence,

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Risk Factors for Ischemic Stroke: Electrocardiographic Findings Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead

More information

ARIC Manuscript Proposal # 947. PC Reviewed: 07/01/03 Status: A Priority: 2 SC Reviewed: 07/18/03 Status: A Priority: 2

ARIC Manuscript Proposal # 947. PC Reviewed: 07/01/03 Status: A Priority: 2 SC Reviewed: 07/18/03 Status: A Priority: 2 ARIC Manuscript Proposal # 947 PC Reviewed: 07/01/03 Status: A Priority: 2 SC Reviewed: 07/18/03 Status: A Priority: 2 1.a. Full Title: The Impact of Treatment and Adequate Control of Blood Pressure for

More information

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012

JUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012 SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK

More information

Blood Pressure Usually Considered Normal Is Associated with an Elevated Risk of Cardiovascular Disease

Blood Pressure Usually Considered Normal Is Associated with an Elevated Risk of Cardiovascular Disease The American Journal of Medicine (2006) 119, 133-141 CLINICAL RESEARCH STUDY Blood Pressure Usually Considered Normal Is Associated with an Elevated Risk of Cardiovascular Disease Abhijit V. Kshirsagar,

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

ARIC Manuscript Proposal #1491. PC Reviewed: 03/17/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #1491. PC Reviewed: 03/17/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal #1491 PC Reviewed: 03/17/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: The Association of Hemoglobin A1c with Depressive Symptoms in Persons with and

More information

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 10, 2014 ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 10, 2014 ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 1, 214 ª 214 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 735-197/$36. PUBLISHED BY ELSEVIER INC. http://dx.doi.org/1.116/j.jacc.214.6.1186

More information

National public health campaigns have attempted

National public health campaigns have attempted WINTER 2005 PREVENTIVE CARDIOLOGY 11 CLINICAL STUDY Knowledge of Cholesterol Levels and Targets in Patients With Coronary Artery Disease Susan Cheng, MD; 1,2 Judith H. Lichtman, MPH, PhD; 3 Joan M. Amatruda,

More information

Blood pressure (BP) is an established major risk factor for

Blood pressure (BP) is an established major risk factor for Pulse Pressure Compared With Other Blood Pressure Indexes in the Prediction of 25-Year Cardiovascular and All-Cause Mortality Rates The Chicago Heart Association Detection Project in Industry Study Katsuyuki

More information

The Framingham Coronary Heart Disease Risk Score

The Framingham Coronary Heart Disease Risk Score Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although

More information

INTRODUCTION METHODS. Alanna M. Chamberlain, MPH; Matthew B. Schabath, PhD; Aaron R. Folsom, MD

INTRODUCTION METHODS. Alanna M. Chamberlain, MPH; Matthew B. Schabath, PhD; Aaron R. Folsom, MD ASSOCIATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ALL-CAUSE MORTALITY IN BLACKS AND WHITES: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY Objective: To determine the burden of chronic obstructive

More information

The Atherosclerosis Risk in Communities (ARIC) Study,

The Atherosclerosis Risk in Communities (ARIC) Study, American Journal of Epidemiology Copyright 000 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 1, No. 7 Printed in U.S.A. Education and Common Carotid Artery

More information

ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial

ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial 1 ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial Davis BR, Piller LB, Cutler JA, et al. Circulation 2006.113:2201-2210.

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study 22 High- Blood Pressure Progression to Hypertension in the Framingham Heart Study Mark Leitschuh, L. Adrienne Cupples, William Kannel, David Gagnon, and Aram Chobanian This study sought to determine if

More information